Loading...
VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy
The therapeutic landscape for renal cell carcinoma has changed drastically over the last several years with the emergence of molecularly-targeted therapies. With previous prognostic and predictive tools based on studies of patients treated with cytokine therapies, confirmation of these prior methods...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2009
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2873025/ https://ncbi.nlm.nih.gov/pubmed/19216840 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|